Simian virus 40 in posttransplant lymphoproliferative disorders

Human Pathology

Volumn 37, Issue 9, 2006, Pages 1130-1136

  Vilchez, Regis A ^a   Jauregui, Monica Patricia ^b   Hsi, Eric D ^c   Novoa Takara, Louis ^d   Chang, Chung Che ^e  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b ESCUELA DE MEDICINA Y CIENCIAS DE LA SALUD   (Mexico)

^c LERNER RESEARCH INSTITUTE   (United States)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

^e HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

EBV; Lymphoma; PTLD; SV40; T ag

Indexed keywords

DNA; FORMALDEHYDE; LATENT MEMBRANE PROTEIN 1; PARAFFIN; RNA; VIRUS LARGE T ANTIGEN;

ADOLESCENT; ADULT; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; DNA EXTRACTION; EPSTEIN BARR VIRUS; FEMALE; GENE AMPLIFICATION; GENETIC CODE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHOCYTE; LYMPHOPROLIFERATIVE DISEASE; MALE; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATION; SCHOOL CHILD; SEQUENCE ANALYSIS; SIMIAN VIRUS 40; T LYMPHOCYTE;

ADOLESCENT; ADULT; AGED, 80 AND OVER; ANTIGENS, POLYOMAVIRUS TRANSFORMING; BASE SEQUENCE; BONE MARROW TRANSPLANTATION; CHILD; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; ORGAN TRANSPLANTATION; POLYMERASE CHAIN REACTION; POLYOMAVIRUS INFECTIONS; SIMIAN VIRUS 40; TUMOR VIRUS INFECTIONS;

EID: 33747869045     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2006.04.020     Document Type: Article

References (33)

1. Chang C.C., Novoa-Takara L., Perkins S.L., et al. Histogenetic phenotypes of B cells in posttransplant lymphoproliferative disorders by immunohistochemical analysis correlate with transplant type: solid organ vs hematopoietic stem cell transplantation. Am J Clin Pathol 123 (2005) 104-112
2. Macsween K., and Crawford D.H. Epstein-Barr virus-recent advances. Lancet Infect Dis 3 (2003) 131-140
3. Ghobrial I.M., Habermann T.M., Macon W.R., et al. Differences between early and late posttransplant lymphoproliferative disorders in solid organ transplant patients: are they two different diseases?. Transplantation 79 (2005) 244-247
4. Nalesnik M.A. Clinicopathologic characteristics of post-transplant lymphoproliferative disorders. Recent Results Cancer Res 159 (2002) 9-18
5. Leblond V., Davi F., Charlotte F., et al. Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity?. J Clin Oncol 16 (1998) 2052-2059
6. Dotti G., Fiocchi R., Motta T., et al. Epstein-Barr virus-negative lymphoproliferate disorders in long-term survivors after heart, kidney, and liver transplant. Transplantation 69 (2000) 827-833
7. Butel J.S. Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease. Carcinogenesis 21 (2000) 405-426
8. Martini F., Dolcetti R., Gloghini A., et al. Simian virus 40 footprints in human lymphoproliferative disorders of HIV- and HIV+ patients. Int J Cancer 78 (1998) 669-674
9. Rizzo P., Carbone M., Fisher S.G., et al. Simian virus 40 is present in most United States human mesotheliomas, but it is rarely present in non-Hodgkin's lymphoma. Chest 116 (1999) 470S-473S
10. David H., Mendoza S., Konishi T., and Miller C.W. Simian virus 40 is present in human lymphomas and normal blood. Cancer Lett 162 (2001) 57-64
11. Vilchez R.A., Madden C.R., Kozinetz C.A., et al. Association between simian virus 40 and non-Hodgkin lymphoma. Lancet 359 (2002) 817-823
12. Vilchez R.A., Lednicky J.A., Halvorson S.J., White Z.S., Kozinetz C.A., and Butel J.S. Detection of polyomavirus simian virus 40 tumor antigen DNA in AIDS-related systemic non-Hodgkin lymphoma. J Acquir Immune Defic Syndr 29 (2002) 109-116
13. Shivapurkar N., Harada K., Reddy J., et al. Presence of SV40 virus DNA sequences in human lymphomas. Lancet 359 (2002) 851-852
14. Nakatsuka S., Liu A., Dong Z., et al. Simian virus 40 sequences in malignant lymphomas in Japan. Cancer Res 63 (2003) 7606-7608
15. Shivapurkar N., Takahashi T., Reddy J., et al. Presence of simian virus 40 DNA sequences in human lymphoid and hematopoietic malignancies and their relationship to aberrant promoter methylation of multiple genes. Cancer Res 64 (2004) 3757-3760
16. Heinsohn S., Golta S., Kabish H., and zur Stadt U. Standardized detection of simian virus 40 by real time quantitative polymerase chain reaction in pediatric malignancies. Haematologica 90 (2005) 95-100
17. Vilchez R.A., Lopez-Terrada D., Middleton J.R., et al. Simian virus 40 tumor antigen expression and immunophenotypic profile of AIDS-related non-Hodgkin's lymphoma. Virology 342 (2005) 38-46
18. Meneses A., Lopez-Terrada D., Zanwar P., et al. Lymphoproliferative disorders in Cost Rica and SV40. Haematologica 90 (2005) 1635-1642
19. Vilchez R.A., Kozinetz C.A., Arrington A.S., Madden C.R., and Butel J.S. Simian virus 40 and human cancers. Am J Med 114 (2003) 675-684
20. Stratton K., Alamario D.A., and McCormick M.C. Immunization safety review: SV40 contamination of polio vaccine and cancer (2003), The National Academies Press, Washington (DC)
21. Kwak E.J., Vilchez R.A., Randhawa P., Shapiro R., Butel J.S., and Kusne S. Pathogenesis and management of polyomavirus infection in transplant recipients. Clin Infect Dis 35 (2002) 1081-1087
22. Vilchez R.A., and Butel J.S. Emergent human pathogen simian virus 40 and its role in cancer. Clin Microbiol Rev 17 (2004) 495-508
23. Srinivasan M., Sedmak D., and Jewell S. Effect of fixatives and tissue processing on the content and integrity of nucleic acids. Am J Pathol 161 (2002) 1961-1971
24. Vilchez R.A., Brayton C.F., Wong C., et al. Differential ability of two simian virus 40 strains to induce malignancies in weanling hamsters. Virology 330 (2004) 168-177
25. Sivaraman P., and Lye W.C. Epstein-Barr virus-associated T-cell lymphoma in solid organ transplant recipients. Biomed Pharmacother 55 (2001) 366-368
26. Hanson M.N., Morrison V.A., Peterson B.A., et al. Posttransplant T-cell lymphoproliferative disorders-an aggressive, late complication of solid-organ transplantation. Blood 88 (1996) 3626-3633
27. López-Ríos F., Illei P.B., Rusch V., and Ladanyi M. Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids. Lancet 364 (2004) 1157-1166
28. Zhen H.N., Zhang X., Bu X.Y., et al. Expression of the simian virus 40 large tumor antigen (Tag) and formation of Tag-p53 and Tag-pRB complexes in human brain tumors. Cancer 86 (1999) 2124-2132
29. Carbone M., Rizzo P., Grimley P.M., et al. Simian virus-40 large-T antigen binds p53 in human mesotheliomas. Nat Med 3 (1997) 908-912
30. Waheed I., Guo Z.S., Chen G.A., Weiser T.S., Nguyen D.M., and Schrump D.S. Antisense to SV40 early gene region induces growth arrest and apoptosis in T-antigen-positive human pleural mesothelioma cells. Cancer Res 59 (1999) 6068-6073
31. Sullivan C.S., Grundhoff A.T., Tevethia S., Pipas J.M., and Ganem D. SV40 encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells. Nature 435 (2005) 682-686
32. Lee T.C., Savoldo B., Rooney C.M., et al. Quantitative EBV viral loads and immunosuppression alterations can decrease PTLD incidence in pediatric liver transplant recipients. Am J Transplant 5 (2005) 2222-2228
33. Heslop H.E., Savoldo B., and Rooney C.M. Cellular therapy of Epstein-Barr-virus-associated post-transplant lymphoproliferative disease. Best Pract Res Clin Haematol 17 (2004) 401-413